Skip to main content
. 2023 Feb 11;15(4):1169. doi: 10.3390/cancers15041169
AcCoA acetyl CoA
AD Alzheimer’s disease
Ang2 angiopoietins 2
APC antigen presenting cells
ATT adoptive T T-cell therapy
BCa bladder cancer
BECs blood endothelial cells
CLN cervical lymph node
CNS central nervous system
CSCC cervical squamous cell carcinoma
DCs dendritic cells
EAE encephalomyelitis
ECM extracellular matrix
EVs extracellular vesicles
FAO fatty acid β-oxidation
FRCs fibroblastic reticular cells
GAL8 galectin 8
GBM glioblastoma
HCC hepatocellular carcinoma
HE hepatic encephalopathy
HepNP heparin polysaccharide nanoparticles
HEVs high endothelial venules
ICH intracerebral hemorrhage
IDO 2, 3-dioxygenase
iNOS nitric oxide synthase
LD lipid droplets
LECs lymphatic endothelial cells
LEPCs lymphatic endothelial progenitor cells
LNs lymph nodes
LNSCs lymph node stromal cells
LPS lipopolysaccharide
LSEC liver sinusoidal endothelial cells
MB medulloblastoma
MHC-I major histocompatibility class I complexes
MI myocardial infarction
MLNs mediastinal lymph nodes
MLVs meningeal lymphatic vessels
OSCC oral squamous cell carcinoma
OSS oscillatory shear stress
PDAC pancreatic ductal adenocarcinoma
PDPN podoplanin
PEG the poly(ethylene glycol)
PEGDA polydiacrylate
PGF placental growth factor
PROX1 Prospero homeobox 1
PTAs peripheral tissue antigens
S1P sphingosine 1 phosphate
SAH subarachnoid hemorrhage
TAM tumor-associated macrophages
TLR4 Toll-like receptor 4
TME tumor microenvironment
VEGF vascular endothelial growth factor
LECs lymphatic endothelial cells